@Cristina_AC_X@Emilianooo You just made the point for AI and this is exactly what we are collecting to have Si learn and take over in every industry. Companies are being compensated for this as we speak. I know because I put these deals up for SI companies
Introducing Kardashev-0.7, the world’s first trained swarm made of 32 distinct models
Trained with RL for Population Scaling (RLPS), 32 models organically develop specialization & complementary capabilities, delivering frontier performance at:
- 0.007x ~ 0.02x of the inference cost
- 0.03x of the required memory
Civilization advances through different minds specializing and working together. We’re bringing that principle into AI
@BanburyRoadAI, we’re scaling intelligence by model count, toward civilizations of models that learn to build on one another
@jonfavs An example I'm a human owner of a company. I don't want to talk to other idiotic humans on a daily basis, so I hire an AI lifelike avatar to have the patience and knowledge to talk to my clients worldwide, in a way that makes them feel comfortable Customer success o anything
@NaithanJones Please..I swear people can only think negatively about A.I. The lack of vision and fear today is astounding. Reminds me of Blockchain and crypto tech where people swear it's only scammers. Such surface level thinking.
@BrianSuttererMD Speak for yourself. Tons of use cases. You sound like the same people that said the internet was a fad. I remember. Let them develop a future you can't see because you lack vision. I can almost smell the fear in your post.
@hassaanraza@sonikudzu Continue the good work...don't be consumed by these peoples weakness and lack of vision. You can smell the fear that runs in their blood. These are the same type of people that would cry oppression in the lack of real oppression. Don't let them convince you otherwise.
Introducing Griffin, the first model to pass the video Turing test.
48% of people who talked to it live thought it was a real human. Previous systems have had a pass rate <3%. It is #1 on NVIDIA's benchmark for full-duplex AI video.
It’s the first Human Interaction Model (HIM).
OMG! @Kling_ai 4.0 is OUT TODAY !!!!
I made this musicvideo with it! Here is everything you need to know …
This post is sponsored by Kling AI but they allowed me to create whatever I wanted!
I was one of the first few artists who got early access and used it to make this music video.
What stood out to me most wasn’t just the image quality, but its ability for lipsyncing!
For the lip sync, I used my preferred method: rendering the actual music track with a black frame and combining it with the stills I created.
Same with prompt adherence.
Shaky handheld camera actually felt shaky.
The anamorphic lens look came through.
And with Omni Reference, you can now work with up to 15 references across images, video, voice and elements.
On launch you also get:
• up to 10 keyframes
• 30s generations
• 1080p
• multi-shot support
• improved lip sync
• improved text generation
• much more flexible reference control
Kling 4.0 feels less like “generate me a video” and more like “here are all the ingredients, now direct it.”
oh, and its cheaper than seedance! And 4.0 Flash is A LOT faster too!
Have you tried it? Let me know your thoughts!
Thank you so much for helping me with this one Ben Chimoy!
An AI-designed drug for chronic lung disease dramatically reversed the markers of biological aging in its first clinical trials.
In a clinical trial published in Nature Biotechnology, scientists evaluating the drug rentosertib — developed by generative artificial intelligence for idiopathic pulmonary fibrosis (IPF) — discovered it also significantly lowered biological age.
Evaluating blood-protein samples from 42 trial participants across six independent 'proteomic aging clocks,' the researchers observed a consistent shift toward younger biological profiles, with some models estimating a decline in biological age of up to several years. In contrast, patients receiving a placebo showed virtually no change or even slight increases in their biological aging markers over the 12-week study.
While these results are highly promising, researchers caution that they are still preliminary.
Because idiopathic pulmonary fibrosis is an age-related illness characterized by severe tissue damage and inflammation, it remains unclear whether rentosertib directly targets the aging process itself or if treating the underlying lung disease simply altered the specific blood proteins tracked by the aging clocks.
Furthermore, because the trial was small and lasted only three months, scientists emphasize that larger, longer-term clinical studies are required to verify if these biological age reversals translate to lasting, tangible health benefits for patients.
source: Insilico Medicine. (2026). Integration of proteomic aging clocks in a phase 2a clinical trial of rentosertib. Nature Biotechnology.
@mvanhorn@Muse People are dumb… if you’re not in business to make money, you’re not in business. Get your damn feelings out of the way and take the call AI friendly businesses will take every call you don’t take